Speaker Profile

Director, Market Access, GeneDx

Ashley's work at GeneDx is focused on expanding access to NGS diagnostics for pediatric rare disease. With 15 years of experience in healthcare, Ashley previously held positions in sales, marketing, and market access at leading U.S. pharmaceutical companies and clinical laboratories, such as Illumina, AstraZeneca, Counsyl (now Myriad Women's Health), and Invitae. Her unique background brings an understanding of the challenges facing stakeholders in the implementation of personalized medicine. Being part of a family impacted by rare disease, Ashley has a deeply personal passion for making personalized medicine part of routine clinical care.

Sharing Insights: Payer Coverage of Pediatric Exome and Genome
Payer coverage is vital for personalized medicine to become part of routine clinical care. Over the last 5 years, payer coverage of NGS testing has grown tremendously. We will take a look at where coverage stands today and where it is moving in the years to come.

 Session Abstract – PMWC 2022 Silicon Valley

Track Chair:
Ed Esplin, Invitae

Genetic testing has evolved over time and various applications have successfully made it into the clinical setting. While oncology applications are dominating, we also see a rise in genetic/genomic applications for reproductive health, CVD diagnosis, or early life understanding. Technological advancements are required to scale genetic testing applications delivery including relay of genomic information to clinicians and patients. In parallel to technological challenges, hurdles are also observed when it comes to insight/knowledge extraction, reporting of clinical findings, and scaling of genetic counseling. This track will touch upon these various aspects including successful precision medicine models through biopharma ventures for rare disease understanding and direct to consumer genetic testing.


  • Intro to Genetic Testing Applications
    - Ed Esplin, Invitae
  • The Path to Universal Newborn Sequencing and Disease Prevention
    - Robert C Green, Harvard
  • Evolving Paradigms in Genetic Testing Initiated by Consumers
    - Paldeep S. Atwal, Every Health
  • Models of Successful Precision Medicine through Biopharma Ventures in Rare Disease
    - Daniel Anderson, Invitae
    - Karen Miga, UCSC
  • Pairing Somatic Cancer Testing with Germline Testing
    - Ed Esplin, Invitae
  • Scalable Approaches to Relaying Genomic Information to Clinicians and their Patients
    - Steven Bleyl, Genome Medical
    - Cassie Hajek, Sanford Imagenetics
  • Lessons Learned from Virtual Genetic Counseling
    - Peter Hulick , NorthShore
  • Sharing Insights On Reimbursement
    - Ashley Arthur, GeneDx